Différences
Ci-dessous, les différences entre deux révisions de la page.
Les deux révisions précédentes Révision précédente | Prochaine révisionLes deux révisions suivantes | ||
covid19:covid19-chloroquine [2020/06/25 09:49] – [Revue de presse thématique] Grégory Gutierez | covid19:covid19-chloroquine [2020/07/15 18:34] – [Revue de presse thématique] Grégory Gutierez | ||
---|---|---|---|
Ligne 52: | Ligne 52: | ||
===== Revue de presse thématique ===== | ===== Revue de presse thématique ===== | ||
+ | |||
+ | ^[[https:// | ||
+ | |The original paper, authored by a team of researchers in France, was published in late March in the International Journal of Antimicrobial Agents. (...) Though the paper did go through peer review, that process too was marred with criticism, after it came to light that one of Raoult’s co-authors, Jean-Marc Rolain, was also the editor-in-chief of the journal where it was published. On April 3, the International Society of Antimicrobial Chemotherapy, | ||
^[[https:// | ^[[https:// |